Temsirolimus Impurity 1 | CAS 408321-08-4 - Request Quote
Temsirolimus Impurity 1
| SZ CAT No: | SZ-T011002 |
| CAS No | 408321-08-4 |
| Mol.F. | C55H85NO16 |
| Mol.Wt. | 1016.3 |
| Inv. Status | In Stock |
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Temsirolimus Impurity 1 is chemically . Temsirolimus Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Temsirolimus Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Temsirolimus.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 408321-08-4
Purchase 408321-08-4
Order 408321-08-4
Enquire 408321-08-4
price of 408321-08-4
408321-08-4 Supplier
408321-08-4 Manufacturer
408321-08-4 Exporter
buy high quality Temsirolimus Impurity 1
Purchase Temsirolimus Impurity 1
Temsirolimus Impurity 1 suppliers
Temsirolimus Impurity 1 manufacturers
Temsirolimus Impurity 1 price
Order Temsirolimus Impurity 1
Enquire Temsirolimus Impurity 1
Temsirolimus Impurity 1 cost
Temsirolimus Impurity 1 Supplier
Temsirolimus Impurity 1 Distributor
Temsirolimus Impurity 1 for Method Validation
Temsirolimus Reference Standard
Temsirolimus Impurity 1 for ANDA Filing
Temsirolimus Impurity 1 for Forced Degradation Studies
Temsirolimus Impurity 1 Identification Standards
Temsirolimus Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.